Business · 22/07/2014Updated: 10/17/2026 · 1 min read
Endocrinologic and Metabolic Drug Products Advisory Committee to Hold Meeting
Summary
The Endocrinologic and Metabolic Drug Products Advisory Committee will convene for a meeting, as announced in a recent notice, to discuss and provide recommendations on endocrinologic and metabolic drug products.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →